BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27771773)

  • 21. Narrow-band Imaging International Colorectal Endoscopic Classification to predict polyp histology: REDEFINE study (with videos).
    Repici A; Ciscato C; Correale L; Bisschops R; Bhandari P; Dekker E; Pech O; Radaelli F; Hassan C
    Gastrointest Endosc; 2016 Sep; 84(3):479-486.e3. PubMed ID: 26928372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk.
    Ho V; Ashbury JE; Taylor S; Vanner S; King WD
    Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
    Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
    Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene-specific DNA methylation of DNMT3B and MTHFR and colorectal adenoma risk.
    Ho V; Ashbury JE; Taylor S; Vanner S; King WD
    Mutat Res; 2015 Dec; 782():1-6. PubMed ID: 26485042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The APC E1317Q variant in adenomatous polyps and colorectal cancers.
    Hahnloser D; Petersen GM; Rabe K; Snow K; Lindor NM; Boardman L; Koch B; Doescher D; Wang L; Steenblock K; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1023-8. PubMed ID: 14578138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for advanced colorectal adenomas: a pooled analysis.
    Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
    Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
    Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp Study.
    Shin A; Shrubsole MJ; Ness RM; Wu H; Sinha R; Smalley WE; Shyr Y; Zheng W
    Int J Cancer; 2007 Jul; 121(1):136-42. PubMed ID: 17354224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of high-resolution micro-endoscopy for the classification of colon polyps.
    Tan T; Qu YW; Shu J; Liu ML; Zhang L; Liu HF
    World J Gastroenterol; 2016 Feb; 22(5):1869-76. PubMed ID: 26855546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial.
    Woodson K; Weisenberger DJ; Campan M; Laird PW; Tangrea J; Johnson LL; Schatzkin A; Lanza E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1219-23. PubMed ID: 15894675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
    Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon.
    Yoshida I; Suzuki A; Vallée M; Matano Y; Masunaga T; Zenda T; Shinozaki K; Okada T
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1225-31. PubMed ID: 16979948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas.
    van den Donk M; van Engeland M; Pellis L; Witteman BJ; Kok FJ; Keijer J; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):327-33. PubMed ID: 17301267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps.
    Fliss-Isakov N; Zelber-Sagi S; Webb M; Halpern Z; Shibolet O; Kariv R
    Obesity (Silver Spring); 2017 Nov; 25 Suppl 2():S72-S80. PubMed ID: 29086511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
    Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.
    Nishida H; Urano S
    Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.